» Articles » PMID: 34023891

Thymomectomy Plus Total Thymectomy Versus Simple Thymomectomy for Early-stage Thymoma Without Myasthenia Gravis: a European Society of Thoracic Surgeons Thymic Working Group Study

Abstract

Objectives: Resection of thymic tumours including the removal of both the tumour and the thymus gland (thymothymectomy; TT) is the procedure of choice and is recommended in most relevant articles in the literature. Nevertheless, in recent years, some authors have suggested that resection of the tumour (simple thymomectomy; ST) may suffice from an oncological standpoint in patients with early-stage thymoma who do not have myasthenia gravis (MG) (non-MG). The goal of our study was to compare the short- and long-term outcomes of ST versus TT in non-MG early-stage thymomas using the European Society of Thoracic Surgeons thymic database.

Methods: A total of 498 non-MG patients with pathological stage I thymoma were included in the study. TT was performed in 466 (93.6%) of 498 patients who had surgery with curative intent; ST was done in 32 (6.4%). The completeness of resection, the rate of complications, the 30-day mortality, the overall recurrence and the freedom from recurrence were compared. We performed crude and propensity score-adjusted comparisons by surgical approach (ST vs TT).

Results: TT showed the same rate of postoperative complications, 30-day mortality and postoperative length of stay as ST. The 5-year overall survival rate was 89% in the TT group and 55% in the ST group. The 5-year freedom from recurrence was 96% in the TT group and 79% in the ST group.

Conclusion: Patients with early-stage thymoma without MG who have a TT show significantly better freedom from recurrence than those who have an ST, without an increase in postoperative morbidity rate.

Citing Articles

Minimally invasive thymectomy for patients with thymoma: surgical, oncological and neurological outcomes.

Kumar A, Mittal S, Parshad R, Bhattacharjee H, Suhani , Sharma R Indian J Thorac Cardiovasc Surg. 2024; 41(1):18-26.

PMID: 39679093 PMC: 11638431. DOI: 10.1007/s12055-024-01761-2.


Surgical treatment of thymic epithelial tumor and myasthenia gravis.

Ozcibik Isik G, Turna A Front Surg. 2024; 11:1467789.

PMID: 39624461 PMC: 11609204. DOI: 10.3389/fsurg.2024.1467789.


Early stage thymoma and the surgical extent paradigm.

Kocaman G, Kayi Cangir A Updates Surg. 2024; 76(7):2541-2547.

PMID: 38913297 PMC: 11602822. DOI: 10.1007/s13304-024-01918-z.


Relevance of robotic surgery for thymoma: a narrative review.

Miyajima M, Watanabe A Mediastinum. 2024; 8:29.

PMID: 38881811 PMC: 11177001. DOI: 10.21037/med-23-37.


Perspectives on surgical treatment for thymic epithelial tumors: a narrative review.

Nabe Y, Inoue M, Yoshida J Gland Surg. 2024; 13(2):225-235.

PMID: 38455346 PMC: 10915418. DOI: 10.21037/gs-23-453.


References
1.
Huang J, Detterbeck F, Wang Z, Loehrer Sr P . Standard outcome measures for thymic malignancies. J Thorac Oncol. 2011; 6(7 Suppl 3):S1691-7. DOI: 10.1097/JTO.0b013e3182254ac1. View

2.
Bae M, Lee S, Kim H, Park S, Park I, Kim D . Recurrence after thymoma resection according to the extent of the resection. J Cardiothorac Surg. 2014; 9:51. PMC: 3994658. DOI: 10.1186/1749-8090-9-51. View

3.
Nakagawa K, Yokoi K, Nakajima J, Tanaka F, Maniwa Y, Suzuki M . Is Thymomectomy Alone Appropriate for Stage I (T1N0M0) Thymoma? Results of a Propensity-Score Analysis. Ann Thorac Surg. 2015; 101(2):520-6. DOI: 10.1016/j.athoracsur.2015.07.084. View

4.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E . Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991; 51(1):152-6. DOI: 10.1016/0003-4975(91)90478-9. View

5.
Onuki T, Ishikawa S, Iguchi K, Goto Y, Sakai M, Inagaki M . Limited thymectomy for stage I or II thymomas. Lung Cancer. 2009; 68(3):460-5. DOI: 10.1016/j.lungcan.2009.08.001. View